The Tetanus drugs in development market research report provides comprehensive information on the therapeutics under development for Tetanus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Tetanus. Buy the report here.

The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Tetanus and features dormant and discontinued products.

GlobalData tracks 50 drugs in development for Tetanus by 32 companies/universities/institutes. The top development phase for Tetanus is preclinical with 17 drugs in that stage. The Tetanus pipeline has 48 drugs in development by companies and two by universities/ institutes. Some of the companies in the Tetanus pipeline products market are: CanSino Biologics, AIM Vaccine and Serum Institute of India.

The key targets in the Tetanus pipeline products market include Tetanus Toxin, Pertussis Toxin, and Diphtheria Toxin.

The key mechanisms of action in the Tetanus pipeline product include Tetanus Toxin Inhibitor with one drug in Phase III. The Tetanus pipeline products include three routes of administration with the top ROA being Intramuscular and eight key molecule types in the Tetanus pipeline products market including Toxoid Vaccine, and Inactivated Vaccine.

Tetanus overview

Tetanus is a serious illness caused by Clostridium bacteria. Signs and symptoms of tetanus include spasms and stiffness in jaw muscles, difficulty swallowing, stiffness of abdominal muscles, fever, sweating, elevated blood pressure, and rapid heart rate. The predisposing factors include burns, surgical wounds, ear infections, swelling around the injury, and infected foot ulcers. Treatment includes antibiotics, sedatives, and beta blockers.

For a complete picture of Tetanus’s pipeline drug market, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.